Browse Infectious Disease Articles by Topic

Antibiotic Stewardship: Who’s Responsible?

A joint Pew/AMA survey about resistance and prescribing habits sheds light on provider attitudes and the work ahead.

Congress Considers Legislation Addressing Healthcare Provider Mental Health

The COVID-19 pandemic has placed historic burdens on already-taxed frontline clinicians.

High Lateral Infarction, or Something Else?

The ECG in the figure was obtained from a man with new onset palpitations. What is the probable cause of his symptoms? Is there high lateral infarction, or is something else accounting for the Q waves in leads I and aVL?

Fostemsavir Extended-Release Tablets (Rukobia)

Fostemsavir is indicated, with other antiretrovirals, to treat HIV-1 infections in heavily treatment-experienced adults with multidrug-resistant HIV-1 infections who are failing current regimens.

COVID-19 and Steroids: Is There a Consensus?

A study of adults admitted with COVID-19 pneumonia revealed risk factors associated with developing acute respiratory distress syndrome (ARDS) and progression from ARDS to death included older age, neutrophilia, organ dysfunction, and coagulation derangement.

Inappropriately Broad Empiric Antibiotics, Higher Mortality, and Community-Onset Sepsis

A retrospective cohort study revealed broad-spectrum antibiotics were unnecessarily prescribed to patients with community-onset sepsis and were associated with worse outcomes and higher mortality.

Thin Evidence Supporting the Obesity Paradox in STEMI

This largest-to-date analysis of six randomized studies of ST-elevation myocardial infarction revealed no association between body mass index and infarct size, one-year mortality, or heart failure hospitalization.

Study: No Relationship Between Blood Type, COVID-19 Severity

But those with certain blood types may be at higher risk for testing positive.

Infectious Disease Alert Updates

Metronidazole Neurotoxicity Is Real; 2020 Updated LTBI Treatment Guidelines; Risks of Hookah Smoking

A New Treatment for Recurrent Bacterial Vaginosis?

In this randomized controlled trial of 228 women, Lactobacillus crispatus CTV-05 (Lactin-V) applied vaginally for 11 weeks reduced the incidence of recurrent bacterial vaginosis from 45% in the placebo arm to 30% in the Lactin-V arm.